The worldwide plant tissue culture market is pegged at about USD 480 million in 2024 and could touch nearly USD 883 million by 2031, growing at a steady CAGR of 9.1% during 2024–2031. Sheel Biotech is already active in this space and plans to roll out its IPO this September.
Narnolia Financial Services will be the Sheel Biotech IPO manager and Skyline Financial Services will register this IPO Also, check the allotment status.
See the Sheel Biotech DRHP and RHP.
Note: For Sheel Biotech Ltd, 50% of the IPO shares will become tradable 30 days after allotment, and the remaining portion will be released from lock-in after 90 days.
The whole company profile of Sheel Biotech is given below:
Let's see what all the investors should know about the Sheel Biotech company IPO.
Check out the major risks and strengths of Sheel Biotech Limited:
Big Plant Capacity: With ISO certifications and a DBT-recognized lab that can handle 10 million plants, the company has strong quality services.
Serving Many States: From government projects to private clients, Chiraharit already has a wide footprint across India.
Leaders Who Know the Field: Promoters bring deep knowledge, global exposure, and years of experience.
Beyond Just Business: The company works on farmer empowerment and skill-building.
Legal Hurdles: Pending disputes and litigation around land may slow down or impact operations.
Supplier Dependence: Have only a few top suppliers for raw materials.
Project Delays Hurt: Timely government project delivery is important; any delays could affect future contracts and revenue.
Uncertain Market Entry: Since this is its first-ever public issue with no trading history, the stock performance is still uncertain.
The Sheel Biotech IPO GMP was not announced on 29 September 2025. You can still check out the company’s profile and its DRHP to gather insights.
Also, check the latest GMP here.
Before applying, you must also see the live subscription numbers. Apply today.
1. How is the Sheel Biotech IPO review?
Sheel Biotech is seen as an agriculture service-based company, with expansion capital as a key objective. For the latest sentiment, you can look for the GMP updates.
2. What is the Sheel Biotech IPO date?
The IPO open date is 30 September 2025, and the closing date is 3 October 2025. But one can monitor live subscription and Sheel Biotech turnover details in real time.
3. What is the Sheel Biotech share price?
The Sheel Biotech IPO price is ₹59-₹63 as per the latest Sheel Biotech IPO news. The final issue price will fall within this range. Also, don't forget to check the Sheel Biotech IPO allotment details.
4. Should I use a demat account to bid for the Sheel Biotech IPO?
Yes, a demat account is required to bid for the Sheel Biotech IPO. Click here to get the ultimate list of the top demat account providers.
